Research suggests depression assessment questionnaires can’t reliably compare people with differing intelligence ...
Nicholas Richardson, DO, MPH, discussed the implications of the FDA’s January draft guidance proposing MRD-negative complete ...
Invivyd expects to advance VBY329 toward IND readiness in 2H 2026 for development in pediatric RSV prophylaxis, a blockbuster pharmaceutical market in 2024, expected to grow to $3-$4 billion in annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results